KA (kinetabio.com) Koefisien nilai perusahaan marang pendapatan

kinetabio.com (KA) - logo korporat

The development of immunotherapy at Kineta, Inc. (KA) relies on a medical innovation cycle that remains independent of macroeconomic trends. This enterprise value-to-revenue chart visualizes this dynamic, where the indicator expresses the current state of the capitalization valuation metric. Future revenues are based on the commercialization of drugs targeting solid tumors, while a unique scientific approach ensures the company secures high royalties from global pharma behemoths.

Kineta - Multiplikator EV/Sales KA (periode 04.07.2022 - 20.11.2026)

Kineta Inc - rincian analitis lan metrik utama (KA)

- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
Analisis wiwitan perusahaan:Kineta
Sampel barang Kineta

Kineta, Inc. (KA) possesses significant pricing power in the immuno-oncology segment due to the uniqueness of the KVA12.1 antibody, rendering the company's revenue a strategic asset. The current EV/Sales multiple of reflects the total enterprise value excluding debt, allowing investors to assess whether the stock is overvalued relative to actual sales and determine if the price constitutes a value trap.

Pesaing langsung

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|Nilai bisnis marang pendapatan LPTX|INTS - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Sensei Biotherapeutics Inc SNSE|TOVX: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gritstone Bio (GRTS)|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP